565
Views
0
CrossRef citations to date
0
Altmetric
Correction

Correction

This article refers to:
Higher Expression of Caveolin-1 Inhibits Human Small Cell Lung Cancer (SCLC) Apoptosis In Vitro

Article title: Higher Expression of Caveolin-1 Inhibits Human Small Cell Lung Cancer (SCLC) Apoptosis In Vitro

Authors: Xiaohan Yang, Hai Xiong, Zhu-zhu Guan, Isaac Okai, Dongmei Ye, Yang Song, Xiao Li, Lan Wang, Lu Liu, Sha Du, Dongmei Lin, and Shujuan Shao

Journal: Cancer Investigation

Bibliometrics: Volume 30, No. 6, page 453–462

DOI: https://doi.org/ 10.3109/07357907.2012.675384

When this article was first published online, the Figures 2a, 3a, 6a, 6b, and 8a were incorrect.

There are also corrections in various parts of the text. The corrections are as follows:

1. Correct the first paragraph of “RESULTS” section to be a part of “MATERIAL AND METHODS” section and add reference number 11 at the end of the paragraph.

2. Add reference number 11 in Figure 1 note.

3. Replace the reference 11 with “11. Sun MZ, Guan Z, Liu S, Zhou X, Wang N, Shao S, Lin D. Caveolin-1 interferes cell growth of lung cancer NCI-H446 cell through the interactions with phospho-ERK1/2, estrogen receptor and progestin receptor. Biomed Pharmacother. 2012; 66:242–248.”

Below are the corrected version of the figures.

Figure 2(a).

Figure 2(a).  

Figure 3(a).

Figure 3(a).  

Figure 6(a) and (b).

Figure 6(a) and (b).  

Figure 8(a).

Figure 8(a).  

The online version of this article has been corrected.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.